Buscar
Mostrando ítems 1-10 de 41
Combined pleuroscopy and endobronchial ultrasound for diagnosis and staging of suspected lung cancer
(2018)
The standard approach to staging of lung cancer in patients with pleural effusion (clinical M1a) is thoracentesis followed by pleural biopsies if the cytologic analysis is negative. If pleural biopsy findings are negative, ...
Endobronchial ultrasound application for diagnosis of tracheobronchial tree invasion by esophageal cancer
(Faculdade de Medicina / USP, 2009)
INTRODUCTION: Esophageal cancer staging has been performed through bronchoscopy, computerized tomography (CT), positron emission tomography (PET), and endoscopic ultrasound (EUS). Whereas CT and PET scan provide assessments ...
Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis
(Hindawi Publishing Corp., 2016)
Introduction. Endobronchial ultrasound (EBUS) is a procedure that provides access to the mediastinal staging; however, EBUS cannot be used to stage all of the nodes in the mediastinum. In these cases, endoscopic ultrasound ...
Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis
(Hindawi Publishing Corp., 2017)
Treatment of isolated mediastinal and hilar recurrence of lung cancer with bronchoscopic endobronchial ultrasound guided intratumoral injection of chemotherapy with cisplatin.
(Elsevier Ireland Ltd., 2015)
PURPOSE:
A common pattern of recurrence in lung cancer after receiving full dose external beam radiation therapy (EBRT) to targeted sites is isolated mediastinal and hilar recurrence (IMHR). Treatment options for these ...
Usefulness of endobronchial ultrasound in patients with human immunodeficiency virus infection and mediastinal lymphadenopathy
(Karger, 2017)
BACKGROUND:
There are few published studies about the usefulness of endobronchial ultrasound (EBUS) in patients infected with human immunodeficiency virus (HIV). The clinical spectrum of likely diseases in this population ...
Clinical performance of endobronchial ultrasound‐guided transbronchial needle aspiration for assessing programmed death ligand‐1 expression in nonsmall cell lung cancer
(Wiley Periodicals, Inc., 2018)
Background:
Pembrolizumab was recently approved as a first line agent for metastatic NSCLC in patients with high programmed death-ligand 1 (PD-L1) expression.
Objetives:
Since a significant portion of lung cancer is ...